Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.
What’s more, such treatment is linked to remission of non–Hodgkin lymphoma.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
Having either form of viral hepatitis was associated with about a 75 percent increased risk of non–Hodgkin lymphoma in a recent study.
Risk for B cell non-Hodgkin lymphoma increases by as much as 20 to 30 percent in hepatitis C patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.